CBLB and gastric cancer: miR‐141, by targeting Cbl‐b and c‐Cbl, inhibits TRAF2‐mediated K48‐linked polyubiquitination and degradation of caspase‐8, which leads to the induction of apoptosis and hence increases the sensitivity of TRAIL in gastric cancer cells (Fig. 10).